The Toronto Stock Exchange reports that Bellus Health Inc. will be delisted at the close on June 29, 2023. According to the TSX, 14934792 Canada Inc., a corporation existing under the
laws of Canada and a wholly owned subsidiary of GSK
PLC, a public limited company formed under the laws of England and Wales, acquired all of the issued and
outstanding shares pursuant to a plan of arrangement. The TSX reports that Bellus shareholders are entitled to receive $14.75 (U.S.) in cash per Bellus share held.
For more information, see Bellus's management information circular dated May 16, 2023, available on SEDAR.
© 2023 Canjex Publishing Ltd. All rights reserved.